Afutuzumab Market, Global Outlook and Forecast 2022-2028
Afutuzumab, more commonly known as obinutuzumab is a humanized type II monoclonal antibody against CD20 (coded for by MS4A1 for the treatment of Chronic lymphocytic leukemia, CLL. It may have more direct antibody-dependent cell-mediated cytotoxicity and possibly more direct cytotoxicity than previously available type I antibodies such as rituximab and ofatumumab which have more complement-dependent cytotoxicity.
This report contains market size and forecasts of Afutuzumab in global, including the following market information:
Global Afutuzumab Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Afutuzumab Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Afutuzumab companies in 2021 (%)
The global Afutuzumab market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Patent Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Afutuzumab include BOC Sciences, Carbosynth, Roche Group, TargetMol Chemicals, Wonda Science, Absin Bioscience, Chunchuang (Wuhan) Technology, Hubei Kele Fine Chemical and Jiangxi Ruiweier Biotechnology, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Afutuzumab manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Afutuzumab Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Afutuzumab Market Segment Percentages, by Type, 2021 (%)
Global Afutuzumab Market Segment Percentages, by Application, 2021 (%)
Global Afutuzumab Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Afutuzumab revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Afutuzumab revenues share in global market, 2021 (%)
Key companies Afutuzumab sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Afutuzumab sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of Afutuzumab in global, including the following market information:
Global Afutuzumab Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Afutuzumab Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Afutuzumab companies in 2021 (%)
The global Afutuzumab market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Patent Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Afutuzumab include BOC Sciences, Carbosynth, Roche Group, TargetMol Chemicals, Wonda Science, Absin Bioscience, Chunchuang (Wuhan) Technology, Hubei Kele Fine Chemical and Jiangxi Ruiweier Biotechnology, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Afutuzumab manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Afutuzumab Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Afutuzumab Market Segment Percentages, by Type, 2021 (%)
- Patent
- Generic
Global Afutuzumab Market Segment Percentages, by Application, 2021 (%)
- Chronic Lymphocytic Leukemia
- Follicular Lymphoma
Global Afutuzumab Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Afutuzumab revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Afutuzumab revenues share in global market, 2021 (%)
Key companies Afutuzumab sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Afutuzumab sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- BOC Sciences
- Carbosynth
- Roche Group
- TargetMol Chemicals
- Wonda Science
- Absin Bioscience
- Chunchuang (Wuhan) Technology
- Hubei Kele Fine Chemical
- Jiangxi Ruiweier Biotechnology
- Qingdao Jieshikang Biotechnology
- Shanghai Biochempartner
- Shanghai Macklin Biochemical
- Shanghai Qiming Biotechnology
- Shanghai Saimai Biotechnology
- Shanghai Shize Biological Technology
- Shanghai Yifei Biotechnology
- Shanghai Yu'ang Chemical
- Tianmen Hengchang Chemical
- Wuhan Sunrise Technology Development
- Wuhan Yingnuo Pharmaceutical Technology
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Afutuzumab Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Afutuzumab Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL AFUTUZUMAB OVERALL MARKET SIZE
2.1 Global Afutuzumab Market Size: 2021 VS 2028
2.2 Global Afutuzumab Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Afutuzumab Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Afutuzumab Players in Global Market
3.2 Top Global Afutuzumab Companies Ranked by Revenue
3.3 Global Afutuzumab Revenue by Companies
3.4 Global Afutuzumab Sales by Companies
3.5 Global Afutuzumab Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Afutuzumab Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Afutuzumab Product Type
3.8 Tier 1, Tier 2 and Tier 3 Afutuzumab Players in Global Market
3.8.1 List of Global Tier 1 Afutuzumab Companies
3.8.2 List of Global Tier 2 and Tier 3 Afutuzumab Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Afutuzumab Market Size Markets, 2021 & 2028
4.1.2 Patent
4.1.3 Generic
4.2 By Type - Global Afutuzumab Revenue & Forecasts
4.2.1 By Type - Global Afutuzumab Revenue, 2017-2022
4.2.2 By Type - Global Afutuzumab Revenue, 2023-2028
4.2.3 By Type - Global Afutuzumab Revenue Market Share, 2017-2028
4.3 By Type - Global Afutuzumab Sales & Forecasts
4.3.1 By Type - Global Afutuzumab Sales, 2017-2022
4.3.2 By Type - Global Afutuzumab Sales, 2023-2028
4.3.3 By Type - Global Afutuzumab Sales Market Share, 2017-2028
4.4 By Type - Global Afutuzumab Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Afutuzumab Market Size, 2021 & 2028
5.1.2 Chronic Lymphocytic Leukemia
5.1.3 Follicular Lymphoma
5.2 By Application - Global Afutuzumab Revenue & Forecasts
5.2.1 By Application - Global Afutuzumab Revenue, 2017-2022
5.2.2 By Application - Global Afutuzumab Revenue, 2023-2028
5.2.3 By Application - Global Afutuzumab Revenue Market Share, 2017-2028
5.3 By Application - Global Afutuzumab Sales & Forecasts
5.3.1 By Application - Global Afutuzumab Sales, 2017-2022
5.3.2 By Application - Global Afutuzumab Sales, 2023-2028
5.3.3 By Application - Global Afutuzumab Sales Market Share, 2017-2028
5.4 By Application - Global Afutuzumab Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Afutuzumab Market Size, 2021 & 2028
6.2 By Region - Global Afutuzumab Revenue & Forecasts
6.2.1 By Region - Global Afutuzumab Revenue, 2017-2022
6.2.2 By Region - Global Afutuzumab Revenue, 2023-2028
6.2.3 By Region - Global Afutuzumab Revenue Market Share, 2017-2028
6.3 By Region - Global Afutuzumab Sales & Forecasts
6.3.1 By Region - Global Afutuzumab Sales, 2017-2022
6.3.2 By Region - Global Afutuzumab Sales, 2023-2028
6.3.3 By Region - Global Afutuzumab Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Afutuzumab Revenue, 2017-2028
6.4.2 By Country - North America Afutuzumab Sales, 2017-2028
6.4.3 US Afutuzumab Market Size, 2017-2028
6.4.4 Canada Afutuzumab Market Size, 2017-2028
6.4.5 Mexico Afutuzumab Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Afutuzumab Revenue, 2017-2028
6.5.2 By Country - Europe Afutuzumab Sales, 2017-2028
6.5.3 Germany Afutuzumab Market Size, 2017-2028
6.5.4 France Afutuzumab Market Size, 2017-2028
6.5.5 U.K. Afutuzumab Market Size, 2017-2028
6.5.6 Italy Afutuzumab Market Size, 2017-2028
6.5.7 Russia Afutuzumab Market Size, 2017-2028
6.5.8 Nordic Countries Afutuzumab Market Size, 2017-2028
6.5.9 Benelux Afutuzumab Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Afutuzumab Revenue, 2017-2028
6.6.2 By Region - Asia Afutuzumab Sales, 2017-2028
6.6.3 China Afutuzumab Market Size, 2017-2028
6.6.4 Japan Afutuzumab Market Size, 2017-2028
6.6.5 South Korea Afutuzumab Market Size, 2017-2028
6.6.6 Southeast Asia Afutuzumab Market Size, 2017-2028
6.6.7 India Afutuzumab Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Afutuzumab Revenue, 2017-2028
6.7.2 By Country - South America Afutuzumab Sales, 2017-2028
6.7.3 Brazil Afutuzumab Market Size, 2017-2028
6.7.4 Argentina Afutuzumab Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Afutuzumab Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Afutuzumab Sales, 2017-2028
6.8.3 Turkey Afutuzumab Market Size, 2017-2028
6.8.4 Israel Afutuzumab Market Size, 2017-2028
6.8.5 Saudi Arabia Afutuzumab Market Size, 2017-2028
6.8.6 UAE Afutuzumab Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 BOC Sciences
7.1.1 BOC Sciences Corporate Summary
7.1.2 BOC Sciences Business Overview
7.1.3 BOC Sciences Afutuzumab Major Product Offerings
7.1.4 BOC Sciences Afutuzumab Sales and Revenue in Global (2017-2022)
7.1.5 BOC Sciences Key News
7.2 Carbosynth
7.2.1 Carbosynth Corporate Summary
7.2.2 Carbosynth Business Overview
7.2.3 Carbosynth Afutuzumab Major Product Offerings
7.2.4 Carbosynth Afutuzumab Sales and Revenue in Global (2017-2022)
7.2.5 Carbosynth Key News
7.3 Roche Group
7.3.1 Roche Group Corporate Summary
7.3.2 Roche Group Business Overview
7.3.3 Roche Group Afutuzumab Major Product Offerings
7.3.4 Roche Group Afutuzumab Sales and Revenue in Global (2017-2022)
7.3.5 Roche Group Key News
7.4 TargetMol Chemicals
7.4.1 TargetMol Chemicals Corporate Summary
7.4.2 TargetMol Chemicals Business Overview
7.4.3 TargetMol Chemicals Afutuzumab Major Product Offerings
7.4.4 TargetMol Chemicals Afutuzumab Sales and Revenue in Global (2017-2022)
7.4.5 TargetMol Chemicals Key News
7.5 Wonda Science
7.5.1 Wonda Science Corporate Summary
7.5.2 Wonda Science Business Overview
7.5.3 Wonda Science Afutuzumab Major Product Offerings
7.5.4 Wonda Science Afutuzumab Sales and Revenue in Global (2017-2022)
7.5.5 Wonda Science Key News
7.6 Absin Bioscience
7.6.1 Absin Bioscience Corporate Summary
7.6.2 Absin Bioscience Business Overview
7.6.3 Absin Bioscience Afutuzumab Major Product Offerings
7.6.4 Absin Bioscience Afutuzumab Sales and Revenue in Global (2017-2022)
7.6.5 Absin Bioscience Key News
7.7 Chunchuang (Wuhan) Technology
7.7.1 Chunchuang (Wuhan) Technology Corporate Summary
7.7.2 Chunchuang (Wuhan) Technology Business Overview
7.7.3 Chunchuang (Wuhan) Technology Afutuzumab Major Product Offerings
7.7.4 Chunchuang (Wuhan) Technology Afutuzumab Sales and Revenue in Global (2017-2022)
7.7.5 Chunchuang (Wuhan) Technology Key News
7.8 Hubei Kele Fine Chemical
7.8.1 Hubei Kele Fine Chemical Corporate Summary
7.8.2 Hubei Kele Fine Chemical Business Overview
7.8.3 Hubei Kele Fine Chemical Afutuzumab Major Product Offerings
7.8.4 Hubei Kele Fine Chemical Afutuzumab Sales and Revenue in Global (2017-2022)
7.8.5 Hubei Kele Fine Chemical Key News
7.9 Jiangxi Ruiweier Biotechnology
7.9.1 Jiangxi Ruiweier Biotechnology Corporate Summary
7.9.2 Jiangxi Ruiweier Biotechnology Business Overview
7.9.3 Jiangxi Ruiweier Biotechnology Afutuzumab Major Product Offerings
7.9.4 Jiangxi Ruiweier Biotechnology Afutuzumab Sales and Revenue in Global (2017-2022)
7.9.5 Jiangxi Ruiweier Biotechnology Key News
7.10 Qingdao Jieshikang Biotechnology
7.10.1 Qingdao Jieshikang Biotechnology Corporate Summary
7.10.2 Qingdao Jieshikang Biotechnology Business Overview
7.10.3 Qingdao Jieshikang Biotechnology Afutuzumab Major Product Offerings
7.10.4 Qingdao Jieshikang Biotechnology Afutuzumab Sales and Revenue in Global (2017-2022)
7.10.5 Qingdao Jieshikang Biotechnology Key News
7.11 Shanghai Biochempartner
7.11.1 Shanghai Biochempartner Corporate Summary
7.11.2 Shanghai Biochempartner Afutuzumab Business Overview
7.11.3 Shanghai Biochempartner Afutuzumab Major Product Offerings
7.11.4 Shanghai Biochempartner Afutuzumab Sales and Revenue in Global (2017-2022)
7.11.5 Shanghai Biochempartner Key News
7.12 Shanghai Macklin Biochemical
7.12.1 Shanghai Macklin Biochemical Corporate Summary
7.12.2 Shanghai Macklin Biochemical Afutuzumab Business Overview
7.12.3 Shanghai Macklin Biochemical Afutuzumab Major Product Offerings
7.12.4 Shanghai Macklin Biochemical Afutuzumab Sales and Revenue in Global (2017-2022)
7.12.5 Shanghai Macklin Biochemical Key News
7.13 Shanghai Qiming Biotechnology
7.13.1 Shanghai Qiming Biotechnology Corporate Summary
7.13.2 Shanghai Qiming Biotechnology Afutuzumab Business Overview
7.13.3 Shanghai Qiming Biotechnology Afutuzumab Major Product Offerings
7.13.4 Shanghai Qiming Biotechnology Afutuzumab Sales and Revenue in Global (2017-2022)
7.13.5 Shanghai Qiming Biotechnology Key News
7.14 Shanghai Saimai Biotechnology
7.14.1 Shanghai Saimai Biotechnology Corporate Summary
7.14.2 Shanghai Saimai Biotechnology Business Overview
7.14.3 Shanghai Saimai Biotechnology Afutuzumab Major Product Offerings
7.14.4 Shanghai Saimai Biotechnology Afutuzumab Sales and Revenue in Global (2017-2022)
7.14.5 Shanghai Saimai Biotechnology Key News
7.15 Shanghai Shize Biological Technology
7.15.1 Shanghai Shize Biological Technology Corporate Summary
7.15.2 Shanghai Shize Biological Technology Business Overview
7.15.3 Shanghai Shize Biological Technology Afutuzumab Major Product Offerings
7.15.4 Shanghai Shize Biological Technology Afutuzumab Sales and Revenue in Global (2017-2022)
7.15.5 Shanghai Shize Biological Technology Key News
7.16 Shanghai Yifei Biotechnology
7.16.1 Shanghai Yifei Biotechnology Corporate Summary
7.16.2 Shanghai Yifei Biotechnology Business Overview
7.16.3 Shanghai Yifei Biotechnology Afutuzumab Major Product Offerings
7.16.4 Shanghai Yifei Biotechnology Afutuzumab Sales and Revenue in Global (2017-2022)
7.16.5 Shanghai Yifei Biotechnology Key News
7.17 Shanghai Yu'ang Chemical
7.17.1 Shanghai Yu'ang Chemical Corporate Summary
7.17.2 Shanghai Yu'ang Chemical Business Overview
7.17.3 Shanghai Yu'ang Chemical Afutuzumab Major Product Offerings
7.17.4 Shanghai Yu'ang Chemical Afutuzumab Sales and Revenue in Global (2017-2022)
7.17.5 Shanghai Yu'ang Chemical Key News
7.18 Tianmen Hengchang Chemical
7.18.1 Tianmen Hengchang Chemical Corporate Summary
7.18.2 Tianmen Hengchang Chemical Business Overview
7.18.3 Tianmen Hengchang Chemical Afutuzumab Major Product Offerings
7.18.4 Tianmen Hengchang Chemical Afutuzumab Sales and Revenue in Global (2017-2022)
7.18.5 Tianmen Hengchang Chemical Key News
7.19 Wuhan Sunrise Technology Development
7.19.1 Wuhan Sunrise Technology Development Corporate Summary
7.19.2 Wuhan Sunrise Technology Development Business Overview
7.19.3 Wuhan Sunrise Technology Development Afutuzumab Major Product Offerings
7.19.4 Wuhan Sunrise Technology Development Afutuzumab Sales and Revenue in Global (2017-2022)
7.19.5 Wuhan Sunrise Technology Development Key News
7.20 Wuhan Yingnuo Pharmaceutical Technology
7.20.1 Wuhan Yingnuo Pharmaceutical Technology Corporate Summary
7.20.2 Wuhan Yingnuo Pharmaceutical Technology Business Overview
7.20.3 Wuhan Yingnuo Pharmaceutical Technology Afutuzumab Major Product Offerings
7.20.4 Wuhan Yingnuo Pharmaceutical Technology Afutuzumab Sales and Revenue in Global (2017-2022)
7.20.5 Wuhan Yingnuo Pharmaceutical Technology Key News
8 GLOBAL AFUTUZUMAB PRODUCTION CAPACITY, ANALYSIS
8.1 Global Afutuzumab Production Capacity, 2017-2028
8.2 Afutuzumab Production Capacity of Key Manufacturers in Global Market
8.3 Global Afutuzumab Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 AFUTUZUMAB SUPPLY CHAIN ANALYSIS
10.1 Afutuzumab Industry Value Chain
10.2 Afutuzumab Upstream Market
10.3 Afutuzumab Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Afutuzumab Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Afutuzumab Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Afutuzumab Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL AFUTUZUMAB OVERALL MARKET SIZE
2.1 Global Afutuzumab Market Size: 2021 VS 2028
2.2 Global Afutuzumab Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Afutuzumab Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Afutuzumab Players in Global Market
3.2 Top Global Afutuzumab Companies Ranked by Revenue
3.3 Global Afutuzumab Revenue by Companies
3.4 Global Afutuzumab Sales by Companies
3.5 Global Afutuzumab Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Afutuzumab Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Afutuzumab Product Type
3.8 Tier 1, Tier 2 and Tier 3 Afutuzumab Players in Global Market
3.8.1 List of Global Tier 1 Afutuzumab Companies
3.8.2 List of Global Tier 2 and Tier 3 Afutuzumab Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Afutuzumab Market Size Markets, 2021 & 2028
4.1.2 Patent
4.1.3 Generic
4.2 By Type - Global Afutuzumab Revenue & Forecasts
4.2.1 By Type - Global Afutuzumab Revenue, 2017-2022
4.2.2 By Type - Global Afutuzumab Revenue, 2023-2028
4.2.3 By Type - Global Afutuzumab Revenue Market Share, 2017-2028
4.3 By Type - Global Afutuzumab Sales & Forecasts
4.3.1 By Type - Global Afutuzumab Sales, 2017-2022
4.3.2 By Type - Global Afutuzumab Sales, 2023-2028
4.3.3 By Type - Global Afutuzumab Sales Market Share, 2017-2028
4.4 By Type - Global Afutuzumab Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Afutuzumab Market Size, 2021 & 2028
5.1.2 Chronic Lymphocytic Leukemia
5.1.3 Follicular Lymphoma
5.2 By Application - Global Afutuzumab Revenue & Forecasts
5.2.1 By Application - Global Afutuzumab Revenue, 2017-2022
5.2.2 By Application - Global Afutuzumab Revenue, 2023-2028
5.2.3 By Application - Global Afutuzumab Revenue Market Share, 2017-2028
5.3 By Application - Global Afutuzumab Sales & Forecasts
5.3.1 By Application - Global Afutuzumab Sales, 2017-2022
5.3.2 By Application - Global Afutuzumab Sales, 2023-2028
5.3.3 By Application - Global Afutuzumab Sales Market Share, 2017-2028
5.4 By Application - Global Afutuzumab Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Afutuzumab Market Size, 2021 & 2028
6.2 By Region - Global Afutuzumab Revenue & Forecasts
6.2.1 By Region - Global Afutuzumab Revenue, 2017-2022
6.2.2 By Region - Global Afutuzumab Revenue, 2023-2028
6.2.3 By Region - Global Afutuzumab Revenue Market Share, 2017-2028
6.3 By Region - Global Afutuzumab Sales & Forecasts
6.3.1 By Region - Global Afutuzumab Sales, 2017-2022
6.3.2 By Region - Global Afutuzumab Sales, 2023-2028
6.3.3 By Region - Global Afutuzumab Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Afutuzumab Revenue, 2017-2028
6.4.2 By Country - North America Afutuzumab Sales, 2017-2028
6.4.3 US Afutuzumab Market Size, 2017-2028
6.4.4 Canada Afutuzumab Market Size, 2017-2028
6.4.5 Mexico Afutuzumab Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Afutuzumab Revenue, 2017-2028
6.5.2 By Country - Europe Afutuzumab Sales, 2017-2028
6.5.3 Germany Afutuzumab Market Size, 2017-2028
6.5.4 France Afutuzumab Market Size, 2017-2028
6.5.5 U.K. Afutuzumab Market Size, 2017-2028
6.5.6 Italy Afutuzumab Market Size, 2017-2028
6.5.7 Russia Afutuzumab Market Size, 2017-2028
6.5.8 Nordic Countries Afutuzumab Market Size, 2017-2028
6.5.9 Benelux Afutuzumab Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Afutuzumab Revenue, 2017-2028
6.6.2 By Region - Asia Afutuzumab Sales, 2017-2028
6.6.3 China Afutuzumab Market Size, 2017-2028
6.6.4 Japan Afutuzumab Market Size, 2017-2028
6.6.5 South Korea Afutuzumab Market Size, 2017-2028
6.6.6 Southeast Asia Afutuzumab Market Size, 2017-2028
6.6.7 India Afutuzumab Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Afutuzumab Revenue, 2017-2028
6.7.2 By Country - South America Afutuzumab Sales, 2017-2028
6.7.3 Brazil Afutuzumab Market Size, 2017-2028
6.7.4 Argentina Afutuzumab Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Afutuzumab Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Afutuzumab Sales, 2017-2028
6.8.3 Turkey Afutuzumab Market Size, 2017-2028
6.8.4 Israel Afutuzumab Market Size, 2017-2028
6.8.5 Saudi Arabia Afutuzumab Market Size, 2017-2028
6.8.6 UAE Afutuzumab Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 BOC Sciences
7.1.1 BOC Sciences Corporate Summary
7.1.2 BOC Sciences Business Overview
7.1.3 BOC Sciences Afutuzumab Major Product Offerings
7.1.4 BOC Sciences Afutuzumab Sales and Revenue in Global (2017-2022)
7.1.5 BOC Sciences Key News
7.2 Carbosynth
7.2.1 Carbosynth Corporate Summary
7.2.2 Carbosynth Business Overview
7.2.3 Carbosynth Afutuzumab Major Product Offerings
7.2.4 Carbosynth Afutuzumab Sales and Revenue in Global (2017-2022)
7.2.5 Carbosynth Key News
7.3 Roche Group
7.3.1 Roche Group Corporate Summary
7.3.2 Roche Group Business Overview
7.3.3 Roche Group Afutuzumab Major Product Offerings
7.3.4 Roche Group Afutuzumab Sales and Revenue in Global (2017-2022)
7.3.5 Roche Group Key News
7.4 TargetMol Chemicals
7.4.1 TargetMol Chemicals Corporate Summary
7.4.2 TargetMol Chemicals Business Overview
7.4.3 TargetMol Chemicals Afutuzumab Major Product Offerings
7.4.4 TargetMol Chemicals Afutuzumab Sales and Revenue in Global (2017-2022)
7.4.5 TargetMol Chemicals Key News
7.5 Wonda Science
7.5.1 Wonda Science Corporate Summary
7.5.2 Wonda Science Business Overview
7.5.3 Wonda Science Afutuzumab Major Product Offerings
7.5.4 Wonda Science Afutuzumab Sales and Revenue in Global (2017-2022)
7.5.5 Wonda Science Key News
7.6 Absin Bioscience
7.6.1 Absin Bioscience Corporate Summary
7.6.2 Absin Bioscience Business Overview
7.6.3 Absin Bioscience Afutuzumab Major Product Offerings
7.6.4 Absin Bioscience Afutuzumab Sales and Revenue in Global (2017-2022)
7.6.5 Absin Bioscience Key News
7.7 Chunchuang (Wuhan) Technology
7.7.1 Chunchuang (Wuhan) Technology Corporate Summary
7.7.2 Chunchuang (Wuhan) Technology Business Overview
7.7.3 Chunchuang (Wuhan) Technology Afutuzumab Major Product Offerings
7.7.4 Chunchuang (Wuhan) Technology Afutuzumab Sales and Revenue in Global (2017-2022)
7.7.5 Chunchuang (Wuhan) Technology Key News
7.8 Hubei Kele Fine Chemical
7.8.1 Hubei Kele Fine Chemical Corporate Summary
7.8.2 Hubei Kele Fine Chemical Business Overview
7.8.3 Hubei Kele Fine Chemical Afutuzumab Major Product Offerings
7.8.4 Hubei Kele Fine Chemical Afutuzumab Sales and Revenue in Global (2017-2022)
7.8.5 Hubei Kele Fine Chemical Key News
7.9 Jiangxi Ruiweier Biotechnology
7.9.1 Jiangxi Ruiweier Biotechnology Corporate Summary
7.9.2 Jiangxi Ruiweier Biotechnology Business Overview
7.9.3 Jiangxi Ruiweier Biotechnology Afutuzumab Major Product Offerings
7.9.4 Jiangxi Ruiweier Biotechnology Afutuzumab Sales and Revenue in Global (2017-2022)
7.9.5 Jiangxi Ruiweier Biotechnology Key News
7.10 Qingdao Jieshikang Biotechnology
7.10.1 Qingdao Jieshikang Biotechnology Corporate Summary
7.10.2 Qingdao Jieshikang Biotechnology Business Overview
7.10.3 Qingdao Jieshikang Biotechnology Afutuzumab Major Product Offerings
7.10.4 Qingdao Jieshikang Biotechnology Afutuzumab Sales and Revenue in Global (2017-2022)
7.10.5 Qingdao Jieshikang Biotechnology Key News
7.11 Shanghai Biochempartner
7.11.1 Shanghai Biochempartner Corporate Summary
7.11.2 Shanghai Biochempartner Afutuzumab Business Overview
7.11.3 Shanghai Biochempartner Afutuzumab Major Product Offerings
7.11.4 Shanghai Biochempartner Afutuzumab Sales and Revenue in Global (2017-2022)
7.11.5 Shanghai Biochempartner Key News
7.12 Shanghai Macklin Biochemical
7.12.1 Shanghai Macklin Biochemical Corporate Summary
7.12.2 Shanghai Macklin Biochemical Afutuzumab Business Overview
7.12.3 Shanghai Macklin Biochemical Afutuzumab Major Product Offerings
7.12.4 Shanghai Macklin Biochemical Afutuzumab Sales and Revenue in Global (2017-2022)
7.12.5 Shanghai Macklin Biochemical Key News
7.13 Shanghai Qiming Biotechnology
7.13.1 Shanghai Qiming Biotechnology Corporate Summary
7.13.2 Shanghai Qiming Biotechnology Afutuzumab Business Overview
7.13.3 Shanghai Qiming Biotechnology Afutuzumab Major Product Offerings
7.13.4 Shanghai Qiming Biotechnology Afutuzumab Sales and Revenue in Global (2017-2022)
7.13.5 Shanghai Qiming Biotechnology Key News
7.14 Shanghai Saimai Biotechnology
7.14.1 Shanghai Saimai Biotechnology Corporate Summary
7.14.2 Shanghai Saimai Biotechnology Business Overview
7.14.3 Shanghai Saimai Biotechnology Afutuzumab Major Product Offerings
7.14.4 Shanghai Saimai Biotechnology Afutuzumab Sales and Revenue in Global (2017-2022)
7.14.5 Shanghai Saimai Biotechnology Key News
7.15 Shanghai Shize Biological Technology
7.15.1 Shanghai Shize Biological Technology Corporate Summary
7.15.2 Shanghai Shize Biological Technology Business Overview
7.15.3 Shanghai Shize Biological Technology Afutuzumab Major Product Offerings
7.15.4 Shanghai Shize Biological Technology Afutuzumab Sales and Revenue in Global (2017-2022)
7.15.5 Shanghai Shize Biological Technology Key News
7.16 Shanghai Yifei Biotechnology
7.16.1 Shanghai Yifei Biotechnology Corporate Summary
7.16.2 Shanghai Yifei Biotechnology Business Overview
7.16.3 Shanghai Yifei Biotechnology Afutuzumab Major Product Offerings
7.16.4 Shanghai Yifei Biotechnology Afutuzumab Sales and Revenue in Global (2017-2022)
7.16.5 Shanghai Yifei Biotechnology Key News
7.17 Shanghai Yu'ang Chemical
7.17.1 Shanghai Yu'ang Chemical Corporate Summary
7.17.2 Shanghai Yu'ang Chemical Business Overview
7.17.3 Shanghai Yu'ang Chemical Afutuzumab Major Product Offerings
7.17.4 Shanghai Yu'ang Chemical Afutuzumab Sales and Revenue in Global (2017-2022)
7.17.5 Shanghai Yu'ang Chemical Key News
7.18 Tianmen Hengchang Chemical
7.18.1 Tianmen Hengchang Chemical Corporate Summary
7.18.2 Tianmen Hengchang Chemical Business Overview
7.18.3 Tianmen Hengchang Chemical Afutuzumab Major Product Offerings
7.18.4 Tianmen Hengchang Chemical Afutuzumab Sales and Revenue in Global (2017-2022)
7.18.5 Tianmen Hengchang Chemical Key News
7.19 Wuhan Sunrise Technology Development
7.19.1 Wuhan Sunrise Technology Development Corporate Summary
7.19.2 Wuhan Sunrise Technology Development Business Overview
7.19.3 Wuhan Sunrise Technology Development Afutuzumab Major Product Offerings
7.19.4 Wuhan Sunrise Technology Development Afutuzumab Sales and Revenue in Global (2017-2022)
7.19.5 Wuhan Sunrise Technology Development Key News
7.20 Wuhan Yingnuo Pharmaceutical Technology
7.20.1 Wuhan Yingnuo Pharmaceutical Technology Corporate Summary
7.20.2 Wuhan Yingnuo Pharmaceutical Technology Business Overview
7.20.3 Wuhan Yingnuo Pharmaceutical Technology Afutuzumab Major Product Offerings
7.20.4 Wuhan Yingnuo Pharmaceutical Technology Afutuzumab Sales and Revenue in Global (2017-2022)
7.20.5 Wuhan Yingnuo Pharmaceutical Technology Key News
8 GLOBAL AFUTUZUMAB PRODUCTION CAPACITY, ANALYSIS
8.1 Global Afutuzumab Production Capacity, 2017-2028
8.2 Afutuzumab Production Capacity of Key Manufacturers in Global Market
8.3 Global Afutuzumab Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 AFUTUZUMAB SUPPLY CHAIN ANALYSIS
10.1 Afutuzumab Industry Value Chain
10.2 Afutuzumab Upstream Market
10.3 Afutuzumab Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Afutuzumab Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Afutuzumab in Global Market
Table 2. Top Afutuzumab Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Afutuzumab Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Afutuzumab Revenue Share by Companies, 2017-2022
Table 5. Global Afutuzumab Sales by Companies, (Kg), 2017-2022
Table 6. Global Afutuzumab Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Afutuzumab Price (2017-2022) & (US$/Kg)
Table 8. Global Manufacturers Afutuzumab Product Type
Table 9. List of Global Tier 1 Afutuzumab Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Afutuzumab Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Afutuzumab Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Afutuzumab Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Afutuzumab Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Afutuzumab Sales (Kg), 2017-2022
Table 15. By Type - Global Afutuzumab Sales (Kg), 2023-2028
Table 16. By Application – Global Afutuzumab Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Afutuzumab Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Afutuzumab Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Afutuzumab Sales (Kg), 2017-2022
Table 20. By Application - Global Afutuzumab Sales (Kg), 2023-2028
Table 21. By Region – Global Afutuzumab Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Afutuzumab Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Afutuzumab Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Afutuzumab Sales (Kg), 2017-2022
Table 25. By Region - Global Afutuzumab Sales (Kg), 2023-2028
Table 26. By Country - North America Afutuzumab Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Afutuzumab Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Afutuzumab Sales, (Kg), 2017-2022
Table 29. By Country - North America Afutuzumab Sales, (Kg), 2023-2028
Table 30. By Country - Europe Afutuzumab Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Afutuzumab Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Afutuzumab Sales, (Kg), 2017-2022
Table 33. By Country - Europe Afutuzumab Sales, (Kg), 2023-2028
Table 34. By Region - Asia Afutuzumab Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Afutuzumab Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Afutuzumab Sales, (Kg), 2017-2022
Table 37. By Region - Asia Afutuzumab Sales, (Kg), 2023-2028
Table 38. By Country - South America Afutuzumab Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Afutuzumab Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Afutuzumab Sales, (Kg), 2017-2022
Table 41. By Country - South America Afutuzumab Sales, (Kg), 2023-2028
Table 42. By Country - Middle East & Africa Afutuzumab Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Afutuzumab Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Afutuzumab Sales, (Kg), 2017-2022
Table 45. By Country - Middle East & Africa Afutuzumab Sales, (Kg), 2023-2028
Table 46. BOC Sciences Corporate Summary
Table 47. BOC Sciences Afutuzumab Product Offerings
Table 48. BOC Sciences Afutuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 49. Carbosynth Corporate Summary
Table 50. Carbosynth Afutuzumab Product Offerings
Table 51. Carbosynth Afutuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 52. Roche Group Corporate Summary
Table 53. Roche Group Afutuzumab Product Offerings
Table 54. Roche Group Afutuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 55. TargetMol Chemicals Corporate Summary
Table 56. TargetMol Chemicals Afutuzumab Product Offerings
Table 57. TargetMol Chemicals Afutuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 58. Wonda Science Corporate Summary
Table 59. Wonda Science Afutuzumab Product Offerings
Table 60. Wonda Science Afutuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 61. Absin Bioscience Corporate Summary
Table 62. Absin Bioscience Afutuzumab Product Offerings
Table 63. Absin Bioscience Afutuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 64. Chunchuang (Wuhan) Technology Corporate Summary
Table 65. Chunchuang (Wuhan) Technology Afutuzumab Product Offerings
Table 66. Chunchuang (Wuhan) Technology Afutuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 67. Hubei Kele Fine Chemical Corporate Summary
Table 68. Hubei Kele Fine Chemical Afutuzumab Product Offerings
Table 69. Hubei Kele Fine Chemical Afutuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 70. Jiangxi Ruiweier Biotechnology Corporate Summary
Table 71. Jiangxi Ruiweier Biotechnology Afutuzumab Product Offerings
Table 72. Jiangxi Ruiweier Biotechnology Afutuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 73. Qingdao Jieshikang Biotechnology Corporate Summary
Table 74. Qingdao Jieshikang Biotechnology Afutuzumab Product Offerings
Table 75. Qingdao Jieshikang Biotechnology Afutuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 76. Shanghai Biochempartner Corporate Summary
Table 77. Shanghai Biochempartner Afutuzumab Product Offerings
Table 78. Shanghai Biochempartner Afutuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 79. Shanghai Macklin Biochemical Corporate Summary
Table 80. Shanghai Macklin Biochemical Afutuzumab Product Offerings
Table 81. Shanghai Macklin Biochemical Afutuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 82. Shanghai Qiming Biotechnology Corporate Summary
Table 83. Shanghai Qiming Biotechnology Afutuzumab Product Offerings
Table 84. Shanghai Qiming Biotechnology Afutuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 85. Shanghai Saimai Biotechnology Corporate Summary
Table 86. Shanghai Saimai Biotechnology Afutuzumab Product Offerings
Table 87. Shanghai Saimai Biotechnology Afutuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 88. Shanghai Shize Biological Technology Corporate Summary
Table 89. Shanghai Shize Biological Technology Afutuzumab Product Offerings
Table 90. Shanghai Shize Biological Technology Afutuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 91. Shanghai Yifei Biotechnology Corporate Summary
Table 92. Shanghai Yifei Biotechnology Afutuzumab Product Offerings
Table 93. Shanghai Yifei Biotechnology Afutuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 94. Shanghai Yu'ang Chemical Corporate Summary
Table 95. Shanghai Yu'ang Chemical Afutuzumab Product Offerings
Table 96. Shanghai Yu'ang Chemical Afutuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 97. Tianmen Hengchang Chemical Corporate Summary
Table 98. Tianmen Hengchang Chemical Afutuzumab Product Offerings
Table 99. Tianmen Hengchang Chemical Afutuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 100. Wuhan Sunrise Technology Development Corporate Summary
Table 101. Wuhan Sunrise Technology Development Afutuzumab Product Offerings
Table 102. Wuhan Sunrise Technology Development Afutuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 103. Wuhan Yingnuo Pharmaceutical Technology Corporate Summary
Table 104. Wuhan Yingnuo Pharmaceutical Technology Afutuzumab Product Offerings
Table 105. Wuhan Yingnuo Pharmaceutical Technology Afutuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 106. Afutuzumab Production Capacity (Kg) of Key Manufacturers in Global Market, 2020-2022 (Kg)
Table 107. Global Afutuzumab Capacity Market Share of Key Manufacturers, 2020-2022
Table 108. Global Afutuzumab Production by Region, 2017-2022 (Kg)
Table 109. Global Afutuzumab Production by Region, 2023-2028 (Kg)
Table 110. Afutuzumab Market Opportunities & Trends in Global Market
Table 111. Afutuzumab Market Drivers in Global Market
Table 112. Afutuzumab Market Restraints in Global Market
Table 113. Afutuzumab Raw Materials
Table 114. Afutuzumab Raw Materials Suppliers in Global Market
Table 115. Typical Afutuzumab Downstream
Table 116. Afutuzumab Downstream Clients in Global Market
Table 117. Afutuzumab Distributors and Sales Agents in Global Market
Table 1. Key Players of Afutuzumab in Global Market
Table 2. Top Afutuzumab Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Afutuzumab Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Afutuzumab Revenue Share by Companies, 2017-2022
Table 5. Global Afutuzumab Sales by Companies, (Kg), 2017-2022
Table 6. Global Afutuzumab Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Afutuzumab Price (2017-2022) & (US$/Kg)
Table 8. Global Manufacturers Afutuzumab Product Type
Table 9. List of Global Tier 1 Afutuzumab Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Afutuzumab Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Afutuzumab Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Afutuzumab Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Afutuzumab Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Afutuzumab Sales (Kg), 2017-2022
Table 15. By Type - Global Afutuzumab Sales (Kg), 2023-2028
Table 16. By Application – Global Afutuzumab Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Afutuzumab Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Afutuzumab Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Afutuzumab Sales (Kg), 2017-2022
Table 20. By Application - Global Afutuzumab Sales (Kg), 2023-2028
Table 21. By Region – Global Afutuzumab Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Afutuzumab Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Afutuzumab Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Afutuzumab Sales (Kg), 2017-2022
Table 25. By Region - Global Afutuzumab Sales (Kg), 2023-2028
Table 26. By Country - North America Afutuzumab Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Afutuzumab Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Afutuzumab Sales, (Kg), 2017-2022
Table 29. By Country - North America Afutuzumab Sales, (Kg), 2023-2028
Table 30. By Country - Europe Afutuzumab Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Afutuzumab Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Afutuzumab Sales, (Kg), 2017-2022
Table 33. By Country - Europe Afutuzumab Sales, (Kg), 2023-2028
Table 34. By Region - Asia Afutuzumab Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Afutuzumab Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Afutuzumab Sales, (Kg), 2017-2022
Table 37. By Region - Asia Afutuzumab Sales, (Kg), 2023-2028
Table 38. By Country - South America Afutuzumab Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Afutuzumab Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Afutuzumab Sales, (Kg), 2017-2022
Table 41. By Country - South America Afutuzumab Sales, (Kg), 2023-2028
Table 42. By Country - Middle East & Africa Afutuzumab Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Afutuzumab Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Afutuzumab Sales, (Kg), 2017-2022
Table 45. By Country - Middle East & Africa Afutuzumab Sales, (Kg), 2023-2028
Table 46. BOC Sciences Corporate Summary
Table 47. BOC Sciences Afutuzumab Product Offerings
Table 48. BOC Sciences Afutuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 49. Carbosynth Corporate Summary
Table 50. Carbosynth Afutuzumab Product Offerings
Table 51. Carbosynth Afutuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 52. Roche Group Corporate Summary
Table 53. Roche Group Afutuzumab Product Offerings
Table 54. Roche Group Afutuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 55. TargetMol Chemicals Corporate Summary
Table 56. TargetMol Chemicals Afutuzumab Product Offerings
Table 57. TargetMol Chemicals Afutuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 58. Wonda Science Corporate Summary
Table 59. Wonda Science Afutuzumab Product Offerings
Table 60. Wonda Science Afutuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 61. Absin Bioscience Corporate Summary
Table 62. Absin Bioscience Afutuzumab Product Offerings
Table 63. Absin Bioscience Afutuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 64. Chunchuang (Wuhan) Technology Corporate Summary
Table 65. Chunchuang (Wuhan) Technology Afutuzumab Product Offerings
Table 66. Chunchuang (Wuhan) Technology Afutuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 67. Hubei Kele Fine Chemical Corporate Summary
Table 68. Hubei Kele Fine Chemical Afutuzumab Product Offerings
Table 69. Hubei Kele Fine Chemical Afutuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 70. Jiangxi Ruiweier Biotechnology Corporate Summary
Table 71. Jiangxi Ruiweier Biotechnology Afutuzumab Product Offerings
Table 72. Jiangxi Ruiweier Biotechnology Afutuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 73. Qingdao Jieshikang Biotechnology Corporate Summary
Table 74. Qingdao Jieshikang Biotechnology Afutuzumab Product Offerings
Table 75. Qingdao Jieshikang Biotechnology Afutuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 76. Shanghai Biochempartner Corporate Summary
Table 77. Shanghai Biochempartner Afutuzumab Product Offerings
Table 78. Shanghai Biochempartner Afutuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 79. Shanghai Macklin Biochemical Corporate Summary
Table 80. Shanghai Macklin Biochemical Afutuzumab Product Offerings
Table 81. Shanghai Macklin Biochemical Afutuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 82. Shanghai Qiming Biotechnology Corporate Summary
Table 83. Shanghai Qiming Biotechnology Afutuzumab Product Offerings
Table 84. Shanghai Qiming Biotechnology Afutuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 85. Shanghai Saimai Biotechnology Corporate Summary
Table 86. Shanghai Saimai Biotechnology Afutuzumab Product Offerings
Table 87. Shanghai Saimai Biotechnology Afutuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 88. Shanghai Shize Biological Technology Corporate Summary
Table 89. Shanghai Shize Biological Technology Afutuzumab Product Offerings
Table 90. Shanghai Shize Biological Technology Afutuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 91. Shanghai Yifei Biotechnology Corporate Summary
Table 92. Shanghai Yifei Biotechnology Afutuzumab Product Offerings
Table 93. Shanghai Yifei Biotechnology Afutuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 94. Shanghai Yu'ang Chemical Corporate Summary
Table 95. Shanghai Yu'ang Chemical Afutuzumab Product Offerings
Table 96. Shanghai Yu'ang Chemical Afutuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 97. Tianmen Hengchang Chemical Corporate Summary
Table 98. Tianmen Hengchang Chemical Afutuzumab Product Offerings
Table 99. Tianmen Hengchang Chemical Afutuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 100. Wuhan Sunrise Technology Development Corporate Summary
Table 101. Wuhan Sunrise Technology Development Afutuzumab Product Offerings
Table 102. Wuhan Sunrise Technology Development Afutuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 103. Wuhan Yingnuo Pharmaceutical Technology Corporate Summary
Table 104. Wuhan Yingnuo Pharmaceutical Technology Afutuzumab Product Offerings
Table 105. Wuhan Yingnuo Pharmaceutical Technology Afutuzumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 106. Afutuzumab Production Capacity (Kg) of Key Manufacturers in Global Market, 2020-2022 (Kg)
Table 107. Global Afutuzumab Capacity Market Share of Key Manufacturers, 2020-2022
Table 108. Global Afutuzumab Production by Region, 2017-2022 (Kg)
Table 109. Global Afutuzumab Production by Region, 2023-2028 (Kg)
Table 110. Afutuzumab Market Opportunities & Trends in Global Market
Table 111. Afutuzumab Market Drivers in Global Market
Table 112. Afutuzumab Market Restraints in Global Market
Table 113. Afutuzumab Raw Materials
Table 114. Afutuzumab Raw Materials Suppliers in Global Market
Table 115. Typical Afutuzumab Downstream
Table 116. Afutuzumab Downstream Clients in Global Market
Table 117. Afutuzumab Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Afutuzumab Segment by Type
Figure 2. Afutuzumab Segment by Application
Figure 3. Global Afutuzumab Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Afutuzumab Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Afutuzumab Revenue, 2017-2028 (US$, Mn)
Figure 7. Afutuzumab Sales in Global Market: 2017-2028 (Kg)
Figure 8. The Top 3 and 5 Players Market Share by Afutuzumab Revenue in 2021
Figure 9. By Type - Global Afutuzumab Sales Market Share, 2017-2028
Figure 10. By Type - Global Afutuzumab Revenue Market Share, 2017-2028
Figure 11. By Type - Global Afutuzumab Price (US$/Kg), 2017-2028
Figure 12. By Application - Global Afutuzumab Sales Market Share, 2017-2028
Figure 13. By Application - Global Afutuzumab Revenue Market Share, 2017-2028
Figure 14. By Application - Global Afutuzumab Price (US$/Kg), 2017-2028
Figure 15. By Region - Global Afutuzumab Sales Market Share, 2017-2028
Figure 16. By Region - Global Afutuzumab Revenue Market Share, 2017-2028
Figure 17. By Country - North America Afutuzumab Revenue Market Share, 2017-2028
Figure 18. By Country - North America Afutuzumab Sales Market Share, 2017-2028
Figure 19. US Afutuzumab Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Afutuzumab Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Afutuzumab Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Afutuzumab Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Afutuzumab Sales Market Share, 2017-2028
Figure 24. Germany Afutuzumab Revenue, (US$, Mn), 2017-2028
Figure 25. France Afutuzumab Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Afutuzumab Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Afutuzumab Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Afutuzumab Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Afutuzumab Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Afutuzumab Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Afutuzumab Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Afutuzumab Sales Market Share, 2017-2028
Figure 33. China Afutuzumab Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Afutuzumab Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Afutuzumab Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Afutuzumab Revenue, (US$, Mn), 2017-2028
Figure 37. India Afutuzumab Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Afutuzumab Revenue Market Share, 2017-2028
Figure 39. By Country - South America Afutuzumab Sales Market Share, 2017-2028
Figure 40. Brazil Afutuzumab Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Afutuzumab Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Afutuzumab Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Afutuzumab Sales Market Share, 2017-2028
Figure 44. Turkey Afutuzumab Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Afutuzumab Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Afutuzumab Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Afutuzumab Revenue, (US$, Mn), 2017-2028
Figure 48. Global Afutuzumab Production Capacity (Kg), 2017-2028
Figure 49. The Percentage of Production Afutuzumab by Region, 2021 VS 2028
Figure 50. Afutuzumab Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Afutuzumab Segment by Type
Figure 2. Afutuzumab Segment by Application
Figure 3. Global Afutuzumab Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Afutuzumab Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Afutuzumab Revenue, 2017-2028 (US$, Mn)
Figure 7. Afutuzumab Sales in Global Market: 2017-2028 (Kg)
Figure 8. The Top 3 and 5 Players Market Share by Afutuzumab Revenue in 2021
Figure 9. By Type - Global Afutuzumab Sales Market Share, 2017-2028
Figure 10. By Type - Global Afutuzumab Revenue Market Share, 2017-2028
Figure 11. By Type - Global Afutuzumab Price (US$/Kg), 2017-2028
Figure 12. By Application - Global Afutuzumab Sales Market Share, 2017-2028
Figure 13. By Application - Global Afutuzumab Revenue Market Share, 2017-2028
Figure 14. By Application - Global Afutuzumab Price (US$/Kg), 2017-2028
Figure 15. By Region - Global Afutuzumab Sales Market Share, 2017-2028
Figure 16. By Region - Global Afutuzumab Revenue Market Share, 2017-2028
Figure 17. By Country - North America Afutuzumab Revenue Market Share, 2017-2028
Figure 18. By Country - North America Afutuzumab Sales Market Share, 2017-2028
Figure 19. US Afutuzumab Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Afutuzumab Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Afutuzumab Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Afutuzumab Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Afutuzumab Sales Market Share, 2017-2028
Figure 24. Germany Afutuzumab Revenue, (US$, Mn), 2017-2028
Figure 25. France Afutuzumab Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Afutuzumab Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Afutuzumab Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Afutuzumab Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Afutuzumab Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Afutuzumab Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Afutuzumab Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Afutuzumab Sales Market Share, 2017-2028
Figure 33. China Afutuzumab Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Afutuzumab Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Afutuzumab Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Afutuzumab Revenue, (US$, Mn), 2017-2028
Figure 37. India Afutuzumab Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Afutuzumab Revenue Market Share, 2017-2028
Figure 39. By Country - South America Afutuzumab Sales Market Share, 2017-2028
Figure 40. Brazil Afutuzumab Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Afutuzumab Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Afutuzumab Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Afutuzumab Sales Market Share, 2017-2028
Figure 44. Turkey Afutuzumab Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Afutuzumab Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Afutuzumab Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Afutuzumab Revenue, (US$, Mn), 2017-2028
Figure 48. Global Afutuzumab Production Capacity (Kg), 2017-2028
Figure 49. The Percentage of Production Afutuzumab by Region, 2021 VS 2028
Figure 50. Afutuzumab Industry Value Chain
Figure 51. Marketing Channels
